Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-29

Clinical Trial Update: Transdermal Rotigotine User Surveillance Study

View source ↗

Summary

A completed clinical trial update for a transdermal rotigotine surveillance study in idiopathic Parkinson disease with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine Transdermal System (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Idiopathic Parkinson Disease | Status: COMPLETED | Results posted: 2015-04-29